Filters
Close
ADDED DATE
Added date
TOPICS Please select
WATCH / LISTEN / READ TIME
Author(s): Joost Daemen , Start date: Nov 23, 2023
In light of the recent ESC clinical consensus statement on Renal Denervation (RDN), a significant development has occurred in the management of hypertension. The European Society of Hypertension (ESH) has officially endorsed Renal Denervation as a recommended treatment for hypertension. This marks a pivotal moment in the field of hypertension management. This broadcast will feature a compelling… View more
Author(s): Joost Daemen , Added: 1 year ago
In light of the recent ESC clinical consensus statement on Renal Denervation (RDN), a significant development has occurred in the management of hypertension. The European Society of Hypertension (ESH) has officially endorsed Renal Denervation as a recommended treatment for hypertension. This marks a pivotal moment in the field of hypertension management.This broadcast features a compelling… View more
Added: 1 year ago Source:  ESC Congress
The European Society of Cardiology has revealed 12 Hot-Line trial sessions to be presented at the end of August.ESC Congress 2024 will be held from the 30thAugust to the 2nd September at the ExCel Center in London. View the full programme here.Don't miss our video collection covering late-breaking data from ESC Congress 2024, including a preview of the most anticipated trials in View from the… View more
Job title: Associate Professor of Cardiac Sciences
Job title: Renal Physician and Hypertension Specialist
Prof Markus Schlaich (Royal Perth Hospital and University of Western Australia, Perth, AU) is a Renal Physician and an ESH accredited Hypertension Specialist with a strong background in clinical research. His main scientific interests focus on pathophysiologic aspects of hypertension. Prof Schlaich has a specific interest in treatment modalities targeting the sympathetic nervous system and has… View more
Research Area(s) / Expertise:
Dr Behnam Tehrani is a System Associate Director for Interventional Cardiology, Executive Director of the Cardiac Catheterization Laboratories for Inova and Co-Director of Complex Coronary Therapeutic Program.Dr Behnam Tehrani also serves as an assistant clinical professor of medicine at both George Washington University and the University of Virginia. He is involved in clinical trials and… View more
Job title: Medical Director
Dr Philip Adamson is Medical Director of the Oklahoma Foundation for Cardiovascular Research and founder of the Heart Failure Institute at Oklahoma Heart Hospital. Dr Adamson received his MD & master's of science in cardiovascular physiology and heart failure from the University of Oklahoma Health Sciences Center. He joined the faculty at the University of Oklahoma as a Warren Foundation… View more
Research Area(s) / Expertise:

Atrial Fibrillation

Job title: Associate Professor of Medicine; Laureate Chair in Molecular Medicine; Vice Chief, Cardiovascular Section
Dr Stavrakis is a clinical cardiac electrophysiologist and Associate Professor of Medicine at the University of Oklahoma Health Sciences Center. He is also the Director of Cardiovascular Research at the University of Oklahoma. Dr Stavrakis’ research has focused on autonomic modulation for the treatment of arrhythmias and other cardiovascular diseases, in both animal models and humans. The… View more